Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Intermediate I. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN106795198B enables high yield synthesis. Reduces costs and improves supply chain reliability for oncology intermediate manufacturing globally.
Patent CN105753703B enables eco-friendly asymmetric hydroxylation using molecular oxygen. Delivers high purity intermediates with reduced environmental impact for global supply chains.
Patent CN1101817C reveals a cost-effective route to tetraazamacrocycles using dichloroethane and halide catalysts, offering significant supply chain advantages for MRI contrast agent precursors.
Patent CN115851685A reveals a breakthrough nitrilase mutant for efficient 3-hydroxy-3-methylbutyric acid production, offering significant cost reduction and green manufacturing advantages.
Novel synthesis route for PARP inhibitor intermediates offers significant cost reduction and supply chain reliability for global pharmaceutical manufacturing partners.
Patent CN1343203A details a novel scalable route for 1,4,7,10-tetraazacyclododecane, offering cost reduction in MRI contrast agent manufacturing through improved salt isolation.
Patent CN107935802A reveals a mild Suzuki coupling method using arylsulfonyl fluoride. This breakthrough offers significant cost reduction and supply chain reliability for fine chemical manufacturing.
Patent CN114958934A reveals a novel glutamate dehydrogenase method for L-glufosinate. Achieve high purity and cost reduction in agrochemical intermediate manufacturing.
Patent CN112175892B reveals a novel co-expression engineering bacterium reducing PLP dependency. Discover cost-effective antibiotic intermediate manufacturing solutions.
Patent CN102911079A details a continuous catalytic distillation method for alkoxyl amine hydrochloride, offering high purity and reduced solvent usage for pharmaceutical intermediates.
Novel synthesis route for 2-deoxy-D-glucose via glucosamine. Reduces cost and complexity. Ideal for API manufacturing scale-up and high-purity production.
Patent CN112724003B reveals a safer, high-yield route for 9-fluorenylformaldehyde using mixed alkoxides, offering significant cost reduction in pharmaceutical intermediate manufacturing.
Patent CN110577941A reveals mutated amine dehydrogenase for asymmetric reductive amination. Enables cost reduction in pharmaceutical intermediates manufacturing with high optical purity.
Patent CN111100851B discloses high-efficiency TbSADH mutants for synthesizing chiral biaryl alcohols with >99% ee, offering a green alternative to metal catalysis.
Patent CN102993256B reveals mild ammonium salt method for selective sugar deprotection. Enhances supply chain reliability and reduces manufacturing complexity significantly.
Novel Ti-catalyzed method offers mild conditions and high yields for beta-aminocarboxylate production, ensuring cost-effective supply chain solutions.
Patent CN115611961A reveals a mild elimination route for Cholic Acid Intermediate A2, enabling virus-free API production with scalable supply chain advantages.
Novel transaminase mutant enables high-yield sitagliptin intermediate synthesis with superior stereoselectivity and scalable biocatalytic process efficiency for global supply.
Discover a novel bromfenac sodium synthesis method avoiding indole impurities. Enhanced purity, stable pH, and scalable production for pharmaceutical supply chains.
Patent CN115611961A details a novel chemical synthesis for Cholic Acid Intermediate A2, offering a virus-free alternative to animal extraction with scalable manufacturing capabilities.